Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-019217
Filing Date
2013-03-27
Accepted
2013-03-27 20:05:20
Documents
1
Period of Report
2013-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd374437.html 4  
1 FORM 4 rrd374437.xml 4 9870
  Complete submission text file 0001181431-13-019217.txt   11277
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXCEL VENTURE MANAGEMENT, LLC 800 BOYLSTON ST., STE 2825 BOSTON MA 02199
Business Address
Gullans Steven R. Ph.D. (Reporting) CIK: 0001571997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 13721235